Filing Flows

Filing Flows › Azenta (AZTA) › Q3 FY25

Azenta (AZTA) Q3 FY25 earnings results (third quarter fiscal 2025)

10-Q filed Aug 6, 2025

Azenta (AZTA) reported revenue of $144M for the third quarter fiscal 2025 (Q3 FY25), -0.3% from a year earlier and +0.4% from the quarter before. Operating margin was -0.5%, net loss $52.8M (36.7% of revenue).

Revenue$144M
Year over year-0.3%
Quarter over quarter+0.4%
Operating margin-0.5%
Net earnings−$52.8M

Azenta, Q3 FY25: revenue $144M (-0.3% year over year), operating margin -0.5%, net loss $52.8M, operating cash flow $25.8M. The chart follows the revenue to costs, profit and cash.

Q3 FY25AmountQ/QY/Y
Revenue$144M+0.4%-0.3%
Operating profit−$714K——
Net earnings−$52.8M——
Operating cash flow$25.8M+79%+164%
Free cash flow$15.0M+91%11×

What changed

Revenue was $143.9M in Q3 FY25, roughly flat year over year and roughly flat from the previous quarter. Multiomics was the largest line at 46% of revenue. Core Products lost $3.7M year over year (down 7%), 844% of the total change.

Gross margin was 46.2%, up 1.4 points from a year earlier. Operating costs exceeded revenue by $714K, an operating margin of -0.5%. Operating expenses fell 6% while revenue was flat. The quarter ended with a net loss of $52.8M, wider than the previous quarter's $40.5M loss. Net interest and other expense of $49.5M was the main reason.

Operating cash flow was $25.8M (up 164% year over year). Non-cash charges added back $14.7M of depreciation and amortization and $3.3M of share-based compensation. Working capital and other items added $60.6M. Capital expenditures of $10.8M left free cash flow of $15.0M.

Questions

What was Azenta's revenue in the third quarter fiscal 2025?

Azenta (AZTA) reported revenue of $144M for the third quarter fiscal 2025 (Q3 FY25), -0.3% from a year earlier and +0.4% from the quarter before.

Was Azenta profitable in the third quarter fiscal 2025?

Operating loss was $714K (-0.5% of revenue) and net loss $52.8M.

Open the interactive Sankey →

Source: Azenta 10-Q on SEC EDGAR.